A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Clinical trial NCT06207175 · UNKNOWN

Trial details

NCT number: NCT06207175
Sponsor: Beijing Health Guard Biotechnology, Inc
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus Infection

Start date: 2023-11-21
Primary completion: 2024-11-17
Enrollment: 1260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.